Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?

Objective:Coronavirus disease-2019 (COVID-19) is a disease with respiratory involvement and the virus-induced endothelial dysfunction is pronounced in the clinical course. In COVID-19 patients, to analyze the laboratory findings and the associations may help to better understand the pathophysiology...

Full description

Bibliographic Details
Main Authors: Müfide Arzu Özkarafakılı, Zeynep Mine Yalçınkaya, Mustafa İlteriş Bardakçı, Işıl Kibar Akıllı
Format: Article
Language:English
Published: Galenos Yayinevi 2022-06-01
Series:Bagcilar Medical Bulletin
Subjects:
Online Access: http://behmedicalbulletin.org/archives/archive-detail/article-preview/could-asymmetric-dimethylarginine-have-a-role-in-c/52119
_version_ 1797912656161538048
author Müfide Arzu Özkarafakılı
Zeynep Mine Yalçınkaya
Mustafa İlteriş Bardakçı
Işıl Kibar Akıllı
author_facet Müfide Arzu Özkarafakılı
Zeynep Mine Yalçınkaya
Mustafa İlteriş Bardakçı
Işıl Kibar Akıllı
author_sort Müfide Arzu Özkarafakılı
collection DOAJ
description Objective:Coronavirus disease-2019 (COVID-19) is a disease with respiratory involvement and the virus-induced endothelial dysfunction is pronounced in the clinical course. In COVID-19 patients, to analyze the laboratory findings and the associations may help to better understand the pathophysiology of this disease.Method:We analyzed the laboratory markers including white blood cell, platelet, mean platelet volume, red cell distribution width (RDW), lactate dehydrogenase, procalcitonin, arterial blood gas values and asymmetric dimethylarginine (ADMA) levels of 83 hospitalized COVID-19 patients with pneumonia. Thirty healthy individuals were enrolled as a control group and their laboratory findings were compared.Results:No significant difference of ADMA levels (median value 225.6 μg/L vs 225.6 μg/L) was noted between COVID-19 patients and the control group (p=0.771). ADMA had an inverse correlation with RDW (r=-0.391, p<0.001). C-reactive protein (CRP) was the significant variable when patients were compared to the healthy group (p=0.002).Conclusion:ADMA levels do not increase at the beginning of COVID-19 clinical course. CRP, as an established inflammation marker, has an imperative role in the clinical spectrum of this coronavirus infection.
first_indexed 2024-04-10T11:59:15Z
format Article
id doaj.art-a03113ee74aa47d18ce88b10430ccf7b
institution Directory Open Access Journal
issn 2547-9431
language English
last_indexed 2024-04-10T11:59:15Z
publishDate 2022-06-01
publisher Galenos Yayinevi
record_format Article
series Bagcilar Medical Bulletin
spelling doaj.art-a03113ee74aa47d18ce88b10430ccf7b2023-02-15T16:16:40ZengGalenos YayineviBagcilar Medical Bulletin2547-94312022-06-017210210910.4274/BMB.galenos.2022.2022-01-0613049054Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?Müfide Arzu Özkarafakılı0Zeynep Mine Yalçınkaya1Mustafa İlteriş Bardakçı2Işıl Kibar Akıllı3 University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Chest Diseases, İstanbul, Turkey University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Biochemistry, İstanbul, Turkey University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Chest Diseases, İstanbul, Turkey University of Health Sciences Turkey, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Chest Diseases, İstanbul, Turkey Objective:Coronavirus disease-2019 (COVID-19) is a disease with respiratory involvement and the virus-induced endothelial dysfunction is pronounced in the clinical course. In COVID-19 patients, to analyze the laboratory findings and the associations may help to better understand the pathophysiology of this disease.Method:We analyzed the laboratory markers including white blood cell, platelet, mean platelet volume, red cell distribution width (RDW), lactate dehydrogenase, procalcitonin, arterial blood gas values and asymmetric dimethylarginine (ADMA) levels of 83 hospitalized COVID-19 patients with pneumonia. Thirty healthy individuals were enrolled as a control group and their laboratory findings were compared.Results:No significant difference of ADMA levels (median value 225.6 μg/L vs 225.6 μg/L) was noted between COVID-19 patients and the control group (p=0.771). ADMA had an inverse correlation with RDW (r=-0.391, p<0.001). C-reactive protein (CRP) was the significant variable when patients were compared to the healthy group (p=0.002).Conclusion:ADMA levels do not increase at the beginning of COVID-19 clinical course. CRP, as an established inflammation marker, has an imperative role in the clinical spectrum of this coronavirus infection. http://behmedicalbulletin.org/archives/archive-detail/article-preview/could-asymmetric-dimethylarginine-have-a-role-in-c/52119 admacovid-19infection
spellingShingle Müfide Arzu Özkarafakılı
Zeynep Mine Yalçınkaya
Mustafa İlteriş Bardakçı
Işıl Kibar Akıllı
Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
Bagcilar Medical Bulletin
adma
covid-19
infection
title Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
title_full Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
title_fullStr Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
title_full_unstemmed Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
title_short Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?
title_sort could asymmetric dimethylarginine have a role in covid 19 cases
topic adma
covid-19
infection
url http://behmedicalbulletin.org/archives/archive-detail/article-preview/could-asymmetric-dimethylarginine-have-a-role-in-c/52119
work_keys_str_mv AT mufidearzuozkarafakılı couldasymmetricdimethylargininehavearoleincovid19cases
AT zeynepmineyalcınkaya couldasymmetricdimethylargininehavearoleincovid19cases
AT mustafailterisbardakcı couldasymmetricdimethylargininehavearoleincovid19cases
AT isılkibarakıllı couldasymmetricdimethylargininehavearoleincovid19cases